%% This BibTeX bibliography file was created using BibDesk.
%% https://bibdesk.sourceforge.io/

%% Created for Abbas Rizvi at 2018-12-16 20:54:40 -0500 


%% Saved with string encoding Unicode (UTF-8) 



@article{michigan_imputation,
	Author = {Das, Sayantan and Forer, Lukas and Sch{\"o}nherr, Sebastian and Sidore, Carlo and Locke, Adam E and Kwong, Alan and Vrieze, Scott I and Chew, Emily Y and Levy, Shawn and McGue, Matt and others},
	Date-Added = {2018-12-16 20:54:29 -0500},
	Date-Modified = {2018-12-16 20:54:38 -0500},
	Journal = {Nature genetics},
	Number = {10},
	Pages = {1284},
	Publisher = {Nature Publishing Group},
	Title = {Next-generation genotype imputation service and methods},
	Volume = {48},
	Year = {2016}}

@article{hrc,
	Author = {McCarthy, Shane and Das, Sayantan and Kretzschmar, Warren and Delaneau, Olivier and Wood, Andrew R and Teumer, Alexander and Kang, Hyun Min and Fuchsberger, Christian and Danecek, Petr and Sharp, Kevin and others},
	Date-Added = {2018-12-16 20:53:47 -0500},
	Date-Modified = {2018-12-16 20:53:52 -0500},
	Journal = {Nature genetics},
	Number = {10},
	Pages = {1279},
	Publisher = {Nature Publishing Group},
	Title = {A reference panel of 64,976 haplotypes for genotype imputation},
	Volume = {48},
	Year = {2016}}

@article{variantannotation,
	Author = {Obenchain, Valerie and Lawrence, Michael and Carey, Vincent and Gogarten, Stephanie and Shannon, Paul and Morgan, Martin},
	Date-Added = {2018-12-16 20:53:13 -0500},
	Date-Modified = {2018-12-16 20:53:20 -0500},
	Journal = {Bioinformatics},
	Number = {14},
	Pages = {2076},
	Publisher = {Oxford University Press},
	Title = {VariantAnnotation: a Bioconductor package for exploration and annotation of genetic variants},
	Volume = {30},
	Year = {2014}}

@article{hapgen2,
	Author = {Su, Zhan and Marchini, Jonathan and Donnelly, Peter},
	Date-Added = {2018-12-16 20:52:42 -0500},
	Date-Modified = {2018-12-16 20:52:47 -0500},
	Journal = {Bioinformatics},
	Number = {16},
	Pages = {2304--2305},
	Publisher = {Oxford University Press},
	Title = {HAPGEN2: simulation of multiple disease SNPs},
	Volume = {27},
	Year = {2011}}

@article{genipe,
	Author = {Lemieux Perreault, Louis-Philippe and Legault, Marc-Andr{\'e} and Asselin, G{\'e}raldine and Dube, Marie-Pierre},
	Date-Added = {2018-12-16 20:51:42 -0500},
	Date-Modified = {2018-12-16 20:51:48 -0500},
	Journal = {Bioinformatics},
	Number = {23},
	Pages = {3661--3663},
	Publisher = {Oxford University Press},
	Title = {genipe: an automated genome-wide imputation pipeline with automatic reporting and statistical tools},
	Volume = {32},
	Year = {2016}}

@article{survivalgwas_sv,
	Author = {Syed, Hamzah and Jorgensen, Andrea L and Morris, Andrew P},
	Date-Added = {2018-12-16 20:51:18 -0500},
	Date-Modified = {2018-12-16 20:51:26 -0500},
	Journal = {BMC bioinformatics},
	Number = {1},
	Pages = {265},
	Publisher = {BioMed Central},
	Title = {SurvivalGWAS\_SV: software for the analysis of genome-wide association studies of imputed genotypes with ``time-to-event'' outcomes},
	Volume = {18},
	Year = {2017}}

@article{gwastools,
	Author = {Gogarten, Stephanie M and Bhangale, Tushar and Conomos, Matthew P and Laurie, Cecelia A and McHugh, Caitlin P and Painter, Ian and Zheng, Xiuwen and Crosslin, David R and Levine, David and Lumley, Thomas and others},
	Date-Added = {2018-12-16 20:50:54 -0500},
	Date-Modified = {2018-12-16 20:51:00 -0500},
	Journal = {Bioinformatics},
	Number = {24},
	Pages = {3329--3331},
	Publisher = {Oxford University Press},
	Title = {GWASTools: an R/Bioconductor package for quality control and analysis of genome-wide association studies},
	Volume = {28},
	Year = {2012}}

@article{snptest,
	Author = {Marchini, Jonathan and Howie, Bryan and Myers, Simon and McVean, Gil and Donnelly, Peter},
	Date-Added = {2018-12-16 20:50:14 -0500},
	Date-Modified = {2018-12-16 20:50:24 -0500},
	Journal = {Nature Genetics},
	Number = {7},
	Pages = {906},
	Publisher = {Nature Publishing Group},
	Title = {A new multipoint method for genome-wide association studies by imputation of genotypes},
	Volume = {39},
	Year = {2007}}

@article{plink,
	Author = {Purcell, Shaun and Neale, Benjamin and Todd-Brown, Kathe and Thomas, Lori and Ferreira, Manuel AR and Bender, David and Maller, Julian and Sklar, Pamela and De Bakker, Paul IW and Daly, Mark J and others},
	Date-Added = {2018-12-16 20:48:04 -0500},
	Date-Modified = {2018-12-16 20:48:14 -0500},
	Journal = {The American Journal of Human Genetics},
	Number = {3},
	Pages = {559--575},
	Publisher = {Elsevier},
	Title = {PLINK: a tool set for whole-genome association and population-based linkage analyses},
	Volume = {81},
	Year = {2007}}

@article{colhoun2003,
	Author = {Colhoun, Helen M and McKeigue, Paul M and Smith, George Davey},
	Date-Added = {2018-12-16 17:36:08 -0500},
	Date-Modified = {2018-12-16 17:36:16 -0500},
	Journal = {The Lancet},
	Number = {9360},
	Pages = {865--872},
	Publisher = {Elsevier},
	Title = {Problems of reporting genetic associations with complex outcomes},
	Volume = {361},
	Year = {2003}}

@webpage{r_core,
	Address = {Vienna, Austria},
	Author = {{R Core Team}},
	Date-Added = {2018-12-16 17:27:51 -0500},
	Date-Modified = {2018-12-16 17:27:58 -0500},
	Organization = {R Foundation for Statistical Computing},
	Title = {R: A Language and Environment for Statistical Computing},
	Url = {https://www.R-project.org/},
	Year = {2018},
	Bdsk-Url-1 = {https://www.R-project.org/}}

@article{Schwarzer_2007,
	Author = {Guido Schwarzer},
	Date-Added = {2018-12-16 17:22:03 -0500},
	Date-Modified = {2018-12-16 17:22:42 -0500},
	Journal = {R News},
	Number = {3},
	Pages = {40--45},
	Title = {meta: {A}n {R} package for meta-analysis},
	Volume = {7},
	Year = {2007}}

@article{fine1999,
	Author = {Fine, Jason P and Gray, Robert J},
	Date-Added = {2018-12-16 17:20:00 -0500},
	Date-Modified = {2018-12-16 17:20:08 -0500},
	Journal = {Journal of the American statistical association},
	Number = {446},
	Pages = {496--509},
	Publisher = {Taylor \& Francis},
	Title = {A proportional hazards model for the subdistribution of a competing risk},
	Volume = {94},
	Year = {1999}}

@article{1000genomes,
	Author = {1000 Genomes Project Consortium},
	Date-Added = {2018-12-16 17:13:42 -0500},
	Date-Modified = {2018-12-16 17:15:07 -0500},
	Journal = {Nature},
	Number = {7571},
	Pages = {68},
	Publisher = {Nature Publishing Group},
	Title = {A global reference for human genetic variation},
	Volume = {526},
	Year = {2015}}

@book{Venables_2002,
	Address = {New York},
	Author = {W. N. Venables and B. D. Ripley},
	Date-Added = {2018-12-16 17:08:17 -0500},
	Date-Modified = {2018-12-16 17:08:26 -0500},
	Edition = {Fourth},
	Note = {ISBN 0-387-95457-0},
	Publisher = {Springer},
	Title = {Modern Applied Statistics with S},
	Url = {http://www.stats.ox.ac.uk/pub/MASS4},
	Year = {2002},
	Bdsk-Url-1 = {http://www.stats.ox.ac.uk/pub/MASS4}}

@book{therneau2013,
	Author = {Therneau, Terry M and Grambsch, Patricia M},
	Date-Added = {2018-12-16 17:02:49 -0500},
	Date-Modified = {2018-12-16 17:03:43 -0500},
	Publisher = {Springer Science & Business Media},
	Title = {Modeling survival data: extending the Cox model},
	Year = {2013}}

@article{cox1972,
	Author = {Cox, David R},
	Date-Added = {2018-12-16 16:59:04 -0500},
	Date-Modified = {2018-12-16 16:59:22 -0500},
	Journal = {Journal of the Royal Statistical Society: Series B (Methodological)},
	Number = {2},
	Pages = {187--202},
	Publisher = {Wiley Online Library},
	Title = {Regression models and life-tables},
	Volume = {34},
	Year = {1972}}

@article{DSouza_2017,
	Abstract = {Hematopoietic Cell Transplantation (HCT) is an established curative treatment for a number of malignant and nonmalignant diseases involving the hematopoietic system and some solid tumors. In this report, we provide information about the number of HCT procedures performed in the United States in 2015, and analyze trends and outcomes of HCT as reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). We show that the number of HCTs performed annually continues to increase, as the indications for HCT, preferred donor sources, and graft-versus-host prophylaxis continue to evolve. We report on general overall survival by indication, by disease status at transplantation, and by transplant type. This report provides a current perspective on transplantation activity in the United States with a focus on recent trends in alternative donors and contemporary transplantation practices.},
	Author = {D'Souza, Anita and Lee, Stephanie and Zhu, Xiaochun and Pasquini, Marcelo},
	Date-Added = {2018-12-16 16:39:55 -0500},
	Date-Modified = {2018-12-16 16:40:24 -0500},
	Doi = {10.1016/j.bbmt.2017.05.035},
	Journal = {Biology of Blood and Marrow Transplantation},
	Journal-Full = {Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
	Keywords = {HCT activity; Trends; US},
	Mesh = {Adult; Alemtuzumab; Antilymphocyte Serum; Calcineurin Inhibitors; Child; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Histocompatibility Testing; Humans; Methotrexate; Myeloablative Agonists; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous},
	Month = {Sep},
	Number = {9},
	Pages = {1417-1421},
	Pmc = {PMC5565685},
	Pmid = {28606646},
	Pst = {ppublish},
	Title = {Current Use and Trends in Hematopoietic Cell Transplantation in the United States},
	Volume = {23},
	Year = {2017},
	Bdsk-Url-1 = {https://doi.org/10.1016/j.bbmt.2017.05.035}}

@article{Pasquini_2013,
	Abstract = {Data reported herein indicate increasing use of hematopoietic cell transplants for persons with blood and bone marrow disorders. Recent trends include increasing use of alternative donors including human leukocyte antigen (HLA)-matched unrelated persons and HLA-matched umbilical cord blood cells, increasing use of blood cell rather than bone marrow grafts, and increasing use of reduced-intensity pretransplant conditioning regimens. Many of these shifts are driven by logistical considerations such as the need for donors in persons without an HLA-identical sibling or expanding use of allotransplants to older persons. Many changes in transplant practices are not supported by results of large randomized trials. More data are needed to critically-assess the impact of these changes.},
	Author = {Pasquini, Marcelo and Wang, Zhiwei and Horowitz, Mary M and Gale, Robert Peter},
	Date-Added = {2018-12-16 16:32:52 -0500},
	Date-Modified = {2018-12-16 16:34:43 -0500},
	Journal = {Clinical Transplants},
	Journal-Full = {Clinical transplants},
	Mesh = {Adult; Bone Marrow Transplantation; Cord Blood Stem Cell Transplantation; Global Health; HLA Antigens; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Young Adult},
	Pages = {187-97},
	Pmid = {25095508},
	Pst = {ppublish},
	Title = {2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders},
	Year = {2013}}

@article{Henig_2014,
	Abstract = {Hematopoietic stem cell transplantation is a highly specialized and unique medical procedure. Autologous transplantation allows the administration of high-dose chemotherapy without prolonged bone marrow aplasia. In allogeneic transplantation, donor-derived stem cells provide alloimmunity that enables a graft-versus-tumor effect to eradicate residual disease and prevent relapse. The first allogeneic transplantation was performed by E. Donnall Thomas in 1957. Since then the field has evolved and expanded worldwide. New indications beside acute leukemia and aplastic anemia have been constantly explored and now include congenital disorders of the hematopoietic system, metabolic disorders, and autoimmune disease. The use of matched unrelated donors, umbilical cord blood units, and partially matched related donors has dramatically extended the availability of allogeneic transplantation. Transplant-related mortality has decreased due to improved supportive care, including better strategies to prevent severe infections and with the incorporation of reduced-intensity conditioning protocols that lowered the toxicity and allowed for transplantation in older patients. However, disease relapse and graft-versus-host disease remain the two major causes of mortality with unsatisfactory progress. Intense research aiming to improve adoptive immunotherapy and increase graft-versus-leukemia response while decreasing graft-versus-host response might bring the next breakthrough in allogeneic transplantation. Strategies of graft manipulation, tumor-associated antigen vaccinations, monoclonal antibodies, and adoptive cellular immunotherapy have already proved clinically efficient. In the following years, allogeneic transplantation is likely to become more complex, more individualized, and more efficient. },
	Author = {Henig, Israel and Zuckerman, Tsila},
	Date-Added = {2018-12-16 16:28:54 -0500},
	Date-Modified = {2018-12-16 16:29:47 -0500},
	Doi = {10.5041/RMMJ.10162},
	Journal = {Rambam Maimonides Medical Journal},
	Journal-Full = {Rambam Maimonides Medical Journal},
	Keywords = {Adoptive immunotherapy; alternative donor; conditioning; graft-versus-host disease; graft-versus-leukemia; hematopoietic stem cell transplantation},
	Month = {Oct},
	Number = {4},
	Pages = {e0028},
	Pmc = {PMC4222417},
	Pmid = {25386344},
	Pst = {epublish},
	Title = {Hematopoietic stem cell transplantation-50 years of evolution and future perspectives},
	Volume = {5},
	Year = {2014},
	Bdsk-Url-1 = {https://doi.org/10.5041/RMMJ.10162}}

@article{Martin:2016aa,
	Abstract = {Previous studies have identified single-nucleotide polymorphisms (SNPs) associated with the risk of chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation. The current study determined whether these associations could be replicated in large cohorts of donors and recipients. Each SNP was tested with cohorts of patients having the same donor type (HLA-matched related, unrelated, or both) reported in the original publication, and testing was limited to the same genome (recipient or donor) and genetic model (dominant, recessive, or allelic) reported in the original study. The 21 SNPs reported in this study represent 19 genes, and the analysis encompassed 22 SNP association tests. The hazard ratio (HR) point estimates and risk ratio point estimates corresponding to odds ratios in previous studies consistently fall outside the 95% confidence intervals of HR estimates in the current study. Despite the large size of the cohorts available for the current study, the 95% confidence intervals for most HRs did not exclude 1.0. Three SNPs representing CTLA4, HPSE, and IL1R1 showed evidence of association with the risk of chronic GVHD in unrelated donor-recipient pairs from 1 cohort, but none of these associations was replicated when tested in unrelated donor-recipient pairs from an independent cohort. Two SNPs representing CCR6 and FGFR1OP showed possible associations with the risk of chronic GVHD in related donor-recipient pairs but not in unrelated donor-recipient pairs. These results remain to be tested for replication in other cohorts of related donor-recipient pairs.},
	Author = {Martin, Paul J and Fan, Wenhong and Storer, Barry E and Levine, David M and Zhao, Lue Ping and Warren, Edus H and Flowers, Mary E D and Lee, Stephanie J and Carpenter, Paul A and Boeckh, Michael and Hingorani, Sangeeta and Yan, Li and Hu, Qiang and Preus, Leah and Liu, Song and Spellman, Stephen and Zhu, Xiaochun and Pasquini, Marcelo and McCarthy, Philip and Stram, Daniel and Sheng, Xin and Pooler, Loreall and Haiman, Christopher A and Sucheston-Campbell, Lara and Hahn, Theresa and Hansen, John A},
	Date-Added = {2018-12-16 14:21:01 -0500},
	Date-Modified = {2018-12-16 14:21:01 -0500},
	Doi = {10.1182/blood-2016-07-728063},
	Journal = {Blood},
	Journal-Full = {Blood},
	Mesh = {Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Cohort Studies; Female; Genetic Association Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Infant; Infant, Newborn; Male; Middle Aged; Polymorphism, Single Nucleotide; Transplantation, Homologous; Unrelated Donors; Young Adult},
	Month = {11},
	Number = {20},
	Pages = {2450-2456},
	Pmc = {PMC5114491},
	Pmid = {27758874},
	Pst = {ppublish},
	Title = {Replication of associations between genetic polymorphisms and chronic graft-versus-host disease},
	Volume = {128},
	Year = {2016},
	Bdsk-Url-1 = {https://doi.org/10.1182/blood-2016-07-728063}}

@article{Sucheston-Campbell:2015aa,
	Abstract = {Overall survival following hematopoietic cell transplantation (HCT) has improved over the past two decades through better patient selection and advances in HLA typing, supportive care, and infection prophylaxis. Nonetheless, mortality rates are still unsatisfactory and transplant-related mortality remains a major cause of death after unrelated allogeneic HCT. Since there are no known pre-HCT, non-HLA biologic predictors of survival following transplant, for over a decade, scientists have been investigating the role of non-HLA germline genetic variation in survival and treatment-related mortality after HCT. Variation in single nucleotide polymorphisms (SNPs) has the potential to impact chemotherapy, radiation, and immune responses, leading to different post-HCT survival outcomes. In this paper, we address the current knowledge of the contribution of genetic variation to survival following HCT and discuss study design and methodology for investigating HCT survival on a genomic scale. },
	Author = {Sucheston-Campbell, Lara E and Clay, Alyssa and McCarthy, Philip L and Zhu, Qianqian and Preus, Leah and Pasquini, Marcelo and Onel, Kenan and Hahn, Theresa},
	Date-Added = {2018-12-16 14:20:41 -0500},
	Date-Modified = {2018-12-16 14:48:29 -0500},
	Doi = {10.1007/s11899-014-0246-x},
	Journal = {Current Hematologic Malignancy Reports},
	Journal-Full = {Current hematologic malignancy reports},
	Mesh = {Genetic Variation; Graft vs Host Disease; HLA Antigens; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Polymorphism, Single Nucleotide; Receptors, KIR; Survival Rate; Tissue Donors; Transplant Recipients; Transplantation, Homologous},
	Month = {Mar},
	Number = {1},
	Pages = {45-58},
	Pmc = {PMC4352187},
	Pmid = {25700678},
	Pst = {ppublish},
	Title = {Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?},
	Volume = {10},
	Year = {2015},
	Bdsk-Url-1 = {https://doi.org/10.1007/s11899-014-0246-x}}

@article{Boyle_2012,
	Abstract = {As the sequencing of healthy and disease genomes becomes more commonplace, detailed annotation provides interpretation for individual variation responsible for normal and disease phenotypes. Current approaches focus on direct changes in protein coding genes, particularly nonsynonymous mutations that directly affect the gene product. However, most individual variation occurs outside of genes and, indeed, most markers generated from genome-wide association studies (GWAS) identify variants outside of coding segments. Identification of potential regulatory changes that perturb these sites will lead to a better localization of truly functional variants and interpretation of their effects. We have developed a novel approach and database, RegulomeDB, which guides interpretation of regulatory variants in the human genome. RegulomeDB includes high-throughput, experimental data sets from ENCODE and other sources, as well as computational predictions and manual annotations to identify putative regulatory potential and identify functional variants. These data sources are combined into a powerful tool that scores variants to help separate functional variants from a large pool and provides a small set of putative sites with testable hypotheses as to their function. We demonstrate the applicability of this tool to the annotation of noncoding variants from 69 full sequenced genomes as well as that of a personal genome, where thousands of functionally associated variants were identified. Moreover, we demonstrate a GWAS where the database is able to quickly identify the known associated functional variant and provide a hypothesis as to its function. Overall, we expect this approach and resource to be valuable for the annotation of human genome sequences.},
	Author = {Boyle, Alan P and Hong, Eurie L and Hariharan, Manoj and Cheng, Yong and Schaub, Marc A and Kasowski, Maya and Karczewski, Konrad J and Park, Julie and Hitz, Benjamin C and Weng, Shuai and Cherry, J Michael and Snyder, Michael},
	Date-Added = {2018-12-16 14:20:19 -0500},
	Date-Modified = {2018-12-16 14:46:33 -0500},
	Doi = {10.1101/gr.137323.112},
	Journal = {Genome Research},
	Journal-Full = {Genome research},
	Mesh = {DNA-Binding Proteins; Databases, Genetic; Genetic Variation; Genome, Human; Genome-Wide Association Study; Genotype; Humans; Internet; Intracellular Signaling Peptides and Proteins; Lupus Erythematosus, Systemic; Molecular Sequence Annotation; Nuclear Proteins; Open Reading Frames; Polymorphism, Single Nucleotide; Regulatory Sequences, Nucleic Acid; Tumor Necrosis Factor alpha-Induced Protein 3},
	Month = {Sep},
	Number = {9},
	Pages = {1790-7},
	Pmc = {PMC3431494},
	Pmid = {22955989},
	Pst = {ppublish},
	Title = {Annotation of functional variation in personal genomes using RegulomeDB},
	Volume = {22},
	Year = {2012},
	Bdsk-Url-1 = {https://doi.org/10.1101/gr.137323.112}}

@article{Arnold:2015aa,
	Abstract = {MOTIVATION: Linking genes and functional information to genetic variants identified by association studies remains difficult. Resources containing extensive genomic annotations are available but often not fully utilized due to heterogeneous data formats. To enhance their accessibility, we integrated many annotation datasets into a user-friendly webserver.
AVAILABILITY AND IMPLEMENTATION: http://www.snipa.org/
CONTACT: g.kastenmueller@helmholtz-muenchen.de
SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.},
	Author = {Arnold, Matthias and Raffler, Johannes and Pfeufer, Arne and Suhre, Karsten and Kastenm{\"u}ller, Gabi},
	Date-Added = {2018-12-16 14:19:33 -0500},
	Date-Modified = {2018-12-16 14:19:33 -0500},
	Doi = {10.1093/bioinformatics/btu779},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Mesh = {Databases, Genetic; Genetic Variation; Genome, Human; Genomics; Humans; Molecular Sequence Annotation; Software},
	Month = {Apr},
	Number = {8},
	Pages = {1334-6},
	Pmc = {PMC4393511},
	Pmid = {25431330},
	Pst = {ppublish},
	Title = {SNiPA: an interactive, genetic variant-centered annotation browser},
	Volume = {31},
	Year = {2015},
	Bdsk-Url-1 = {https://doi.org/10.1093/bioinformatics/btu779}}

@article{Mishra_2015,
	Abstract = {Gene-based tests such as versatile gene-based association study (VEGAS) are commonly used following per-single nucleotide polymorphism (SNP) GWAS (genome-wide association studies) analysis. Two limitations of VEGAS were that the HapMap2 reference set was used to model the correlation between SNPs and only autosomal genes were considered. HapMap2 has now been superseded by the 1,000 Genomes reference set, and whereas early GWASs frequently ignored the X chromosome, it is now commonly included. Here we have developed VEGAS2, an extension that uses 1,000 Genomes data to model SNP correlations across the autosomes and chromosome X. VEGAS2 allows greater flexibility when defining gene boundaries. VEGAS2 offers both a user-friendly, web-based front end and a command line Linux version. The online version of VEGAS2 can be accessed through https://vegas2.qimrberghofer.edu.au/. The command line version can be downloaded from https://vegas2.qimrberghofer.edu.au/zVEGAS2offline.tgz. The command line version is developed in Perl, R and shell scripting languages; source code is available for further development. },
	Author = {Mishra, Aniket and Macgregor, Stuart},
	Date-Added = {2018-12-16 14:18:41 -0500},
	Date-Modified = {2018-12-16 14:48:07 -0500},
	Doi = {10.1017/thg.2014.79},
	Journal = {Twin Research and Humans Genetics},
	Journal-Full = {Twin research and human genetics : the official journal of the International Society for Twin Studies},
	Keywords = {VEGAS},
	Mesh = {Chromosomes, Human, X; Computer Simulation; Female; Genetic Association Studies; Genome, Human; Genome-Wide Association Study; HapMap Project; Humans; Internet; Male; Models, Genetic; Online Systems; Polymorphism, Single Nucleotide; Sex Characteristics; Software; Twin Studies as Topic; Twins; User-Computer Interface},
	Month = {Feb},
	Number = {1},
	Pages = {86-91},
	Pmid = {25518859},
	Pst = {ppublish},
	Title = {VEGAS2: Software for More Flexible Gene-Based Testing},
	Volume = {18},
	Year = {2015},
	Bdsk-Url-1 = {https://doi.org/10.1017/thg.2014.79}}

@article{metal,
	Abstract = {SUMMARY: METAL provides a computationally efficient tool for meta-analysis of genome-wide association scans, which is a commonly used approach for improving power complex traits gene mapping studies. METAL provides a rich scripting interface and implements efficient memory management to allow analyses of very large data sets and to support a variety of input file formats.
AVAILABILITY AND IMPLEMENTATION: METAL, including source code, documentation, examples, and executables, is available at http://www.sph.umich.edu/csg/abecasis/metal/.},
	Author = {Willer, Cristen J and Li, Yun and Abecasis, Gon{\c c}alo R},
	Date-Added = {2018-12-16 14:18:02 -0500},
	Date-Modified = {2018-12-16 17:17:23 -0500},
	Doi = {10.1093/bioinformatics/btq340},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Mesh = {Chromosome Mapping; Computational Biology; Genome-Wide Association Study; Software},
	Month = {Sep},
	Number = {17},
	Pages = {2190-1},
	Pmc = {PMC2922887},
	Pmid = {20616382},
	Pst = {ppublish},
	Title = {METAL: fast and efficient meta-analysis of genomewide association scans},
	Volume = {26},
	Year = {2010},
	Bdsk-Url-1 = {https://doi.org/10.1093/bioinformatics/btq340}}

@article{Igl_2009,
	Abstract = {It has been acknowledged that results from genome-wide association studies need to be reproduced in further independent samples. This includes both aspects of replication and validation. Although often used interchangeably, both of these terms have a specific unique meaning and are not synonyms. Based on a number of applications from the literature producing a certain amount of confusion, our aim therefore is to clarify the definition of 'replication' and 'validation' and propose standards of their usage.},
	Author = {Igl, Bernd-Wolfgang and Konig, Inke R and Ziegler, Andreas},
	Date-Added = {2018-12-16 14:17:42 -0500},
	Date-Modified = {2018-12-16 17:17:14 -0500},
	Doi = {10.1159/000164400},
	Journal = {Human Heredity},
	Journal-Full = {Human heredity},
	Mesh = {Genome, Human; Genome-Wide Association Study; Humans; Reproducibility of Results; Research Design; Terminology as Topic; Validation Studies as Topic},
	Number = {1},
	Pages = {66-8},
	Pmid = {18931511},
	Pst = {ppublish},
	Title = {What do we mean by 'replication' and 'validation' in genome-wide association studies?},
	Volume = {67},
	Year = {2009},
	Bdsk-Url-1 = {https://doi.org/10.1159/000164400}}

@article{Ioannidis_2001,
	Abstract = {The rapid growth of human genetics creates countless opportunities for studies of disease association. Given the number of potentially identifiable genetic markers and the multitude of clinical outcomes to which these may be linked, the testing and validation of statistical hypotheses in genetic epidemiology is a task of unprecedented scale. Meta-analysis provides a quantitative approach for combining the results of various studies on the same topic, and for estimating and explaining their diversity. Here, we have evaluated by meta-analysis 370 studies addressing 36 genetic associations for various outcomes of disease. We show that significant between-study heterogeneity (diversity) is frequent, and that the results of the first study correlate only modestly with subsequent research on the same association. The first study often suggests a stronger genetic effect than is found by subsequent studies. Both bias and genuine population diversity might explain why early association studies tend to overestimate the disease protection or predisposition conferred by a genetic polymorphism. We conclude that a systematic meta-analytic approach may assist in estimating population-wide effects of genetic risk factors in human disease.},
	Author = {Ioannidis, J P and Ntzani, E E and Trikalinos, T A and Contopoulos-Ioannidis, D G},
	Date-Added = {2018-12-16 14:16:01 -0500},
	Date-Modified = {2018-12-16 14:47:39 -0500},
	Doi = {10.1038/ng749},
	Journal = {Nature Genetics},
	Journal-Full = {Nature genetics},
	Mesh = {Bias; Chromosome Mapping; Disease; Genetic Linkage; Genetic Markers; Genetic Predisposition to Disease; Genetic Variation; Humans; Meta-Analysis as Topic; Odds Ratio; Polymorphism, Genetic; Regression Analysis; Reproducibility of Results},
	Month = {Nov},
	Number = {3},
	Pages = {306-9},
	Pmid = {11600885},
	Pst = {ppublish},
	Title = {Replication validity of genetic association studies},
	Volume = {29},
	Year = {2001},
	Bdsk-Url-1 = {https://doi.org/10.1038/ng749}}

@article{Howie_2009,
	Abstract = {Genotype imputation methods are now being widely used in the analysis of genome-wide association studies. Most imputation analyses to date have used the HapMap as a reference dataset, but new reference panels (such as controls genotyped on multiple SNP chips and densely typed samples from the 1,000 Genomes Project) will soon allow a broader range of SNPs to be imputed with higher accuracy, thereby increasing power. We describe a genotype imputation method (IMPUTE version 2) that is designed to address the challenges presented by these new datasets. The main innovation of our approach is a flexible modelling framework that increases accuracy and combines information across multiple reference panels while remaining computationally feasible. We find that IMPUTE v2 attains higher accuracy than other methods when the HapMap provides the sole reference panel, but that the size of the panel constrains the improvements that can be made. We also find that imputation accuracy can be greatly enhanced by expanding the reference panel to contain thousands of chromosomes and that IMPUTE v2 outperforms other methods in this setting at both rare and common SNPs, with overall error rates that are 15%-20% lower than those of the closest competing method. One particularly challenging aspect of next-generation association studies is to integrate information across multiple reference panels genotyped on different sets of SNPs; we show that our approach to this problem has practical advantages over other suggested solutions.},
	Author = {Howie, Bryan N and Donnelly, Peter and Marchini, Jonathan},
	Date-Added = {2018-12-16 14:14:18 -0500},
	Date-Modified = {2018-12-16 14:45:52 -0500},
	Doi = {10.1371/journal.pgen.1000529},
	Journal = {PLoS Genetics},
	Journal-Full = {PLoS genetics},
	Mesh = {Genetics, Population; Genome-Wide Association Study; Genotype; Humans; Polymorphism, Single Nucleotide; Software},
	Month = {Jun},
	Number = {6},
	Pages = {e1000529},
	Pmc = {PMC2689936},
	Pmid = {19543373},
	Pst = {ppublish},
	Title = {A flexible and accurate genotype imputation method for the next generation of genome-wide association studies},
	Volume = {5},
	Year = {2009},
	Bdsk-Url-1 = {https://doi.org/10.1371/journal.pgen.1000529}}

@article{Price_AL,
	Abstract = {Population stratification--allele frequency differences between cases and controls due to systematic ancestry differences-can cause spurious associations in disease studies. We describe a method that enables explicit detection and correction of population stratification on a genome-wide scale. Our method uses principal components analysis to explicitly model ancestry differences between cases and controls. The resulting correction is specific to a candidate marker's variation in frequency across ancestral populations, minimizing spurious associations while maximizing power to detect true associations. Our simple, efficient approach can easily be applied to disease studies with hundreds of thousands of markers.},
	Author = {Price, Alkes L and Patterson, Nick J and Plenge, Robert M and Weinblatt, Michael E and Shadick, Nancy A and Reich, David},
	Date-Added = {2018-12-16 14:05:56 -0500},
	Date-Modified = {2018-12-16 14:10:59 -0500},
	Doi = {10.1038/ng1847},
	Journal = {Nature Genetics},
	Journal-Full = {Nature genetics},
	Mesh = {Algorithms; Alleles; Case-Control Studies; Databases, Nucleic Acid; Genetic Markers; Genome, Human; Genomics; Genotype; Humans; Phenotype; Polymorphism, Single Nucleotide; Principal Component Analysis},
	Month = {Aug},
	Number = {8},
	Pages = {904-9},
	Pmid = {16862161},
	Pst = {ppublish},
	Title = {Principal components analysis corrects for stratification in genome-wide association studies},
	Volume = {38},
	Year = {2006},
	Bdsk-Url-1 = {https://doi.org/10.1038/ng1847}}

@article{OSAT,
	Abstract = {BACKGROUND: Batch effect is one type of variability that is not of primary interest but ubiquitous in sizable genomic experiments. To minimize the impact of batch effects, an ideal experiment design should ensure the even distribution of biological groups and confounding factors across batches. However, due to the practical complications, the availability of the final collection of samples in genomics study might be unbalanced and incomplete, which, without appropriate attention in sample-to-batch allocation, could lead to drastic batch effects. Therefore, it is necessary to develop effective and handy tool to assign collected samples across batches in an appropriate way in order to minimize the impact of batch effects.
RESULTS: We describe OSAT (Optimal Sample Assignment Tool), a bioconductor package designed for automated sample-to-batch allocations in genomics experiments.
CONCLUSIONS: OSAT is developed to facilitate the allocation of collected samples to different batches in genomics study. Through optimizing the even distribution of samples in groups of biological interest into different batches, it can reduce the confounding or correlation between batches and the biological variables of interest. It can also optimize the homogeneous distribution of confounding factors across batches. It can handle challenging instances where incomplete and unbalanced sample collections are involved as well as ideally balanced designs.},
	Author = {Yan, Li and Ma, Changxing and Wang, Dan and Hu, Qiang and Qin, Maochun and Conroy, Jeffrey M and Sucheston, Lara E and Ambrosone, Christine B and Johnson, Candace S and Wang, Jianmin and Liu, Song},
	Date-Added = {2018-12-16 14:04:12 -0500},
	Date-Modified = {2018-12-16 14:04:29 -0500},
	Doi = {10.1186/1471-2164-13-689},
	Journal = {BMC Genomics},
	Journal-Full = {BMC genomics},
	Mesh = {Algorithms; Data Collection; Genomics; Software},
	Month = {Dec},
	Pages = {689},
	Pmc = {PMC3548766},
	Pmid = {23228338},
	Pst = {epublish},
	Title = {OSAT: a tool for sample-to-batch allocations in genomics experiments},
	Volume = {13},
	Year = {2012},
	Bdsk-Url-1 = {https://doi.org/10.1186/1471-2164-13-689}}

@article{Hahn_2015,
	Abstract = {Clinical trials commonly use adjudication committees to refine endpoints, but observational research or genome-wide association studies rarely do. Our goals were to establish definitions of cause-specific death after unrelated-donor allogeneic hematopoietic cell transplantation (URD-HCT), to estimate discordance between reported and adjudicated cause-specific death, and to identify factors contributing to inconsistency in cause-specific death determination. A consensus panel adjudicated cause-specific death in 1484 patients who died within 1 year after HCT, derived from 3532 acute leukemia or myelodysplasia patients after URD-HCT from 2000 to 2011 reported by 151 US transplant centers to the Center for International Blood and Marrow Transplant Research. Deaths were classified as disease-related or transplant-related. The panel agreed with >99% of deaths reported by centers as disease-related and 80% reported as transplant-related. Year of transplant (cohort effect) and disease status significantly influenced agreement between the panel and centers. Sensitivity analysis of deaths < 100 days post-transplant yielded the lowest agreement between the panel and centers for myelodysplastic syndrome patients. Standard predefined criteria for adjudicating cause-specific death led to consistent application to similar clinical scenarios and clearer delineation of cause-specific death categories. Other studies of competing events such as cancer-specific versus treatment-related mortality would benefit from our results. Our detailed algorithm should result in more consistent reporting of cause-specific death by centers. },
	Author = {Hahn, Theresa and Sucheston-Campbell, Lara E and Preus, Leah and Zhu, Xiaochun and Hansen, John A and Martin, Paul J and Yan, Li and Liu, Song and Spellman, Stephen and Tritchler, David and Clay, Alyssa and Onel, Kenan and Pasquini, Marcelo and McCarthy, Philip L},
	Date-Added = {2018-12-13 14:28:09 -0500},
	Date-Modified = {2018-12-16 16:49:43 -0500},
	Doi = {10.1016/j.bbmt.2015.05.019},
	Journal = {Biology of Blood and Marrow Transplantation},
	Journal-Full = {Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
	Keywords = {Acute leukemia; Adjudication; Allogeneic HCT; Cause-specific mortality},
	Mesh = {Adult; Aged; Algorithms; Allografts; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Unrelated Donors},
	Month = {Sep},
	Number = {9},
	Pages = {1679-1686},
	Pmc = {PMC4537799},
	Pmid = {26028504},
	Pst = {ppublish},
	Title = {Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation},
	Volume = {21},
	Year = {2015},
	Bdsk-Url-1 = {https://doi.org/10.1016/j.bbmt.2015.05.019}}

@article{Rizvi_2018,
	Abstract = {Summary: To address the limited software options for performing survival analyses with millions of SNPs, we developed gwasurvivr, an R/Bioconductor package with a simple interface for conducting genome wide survival analyses using VCF (outputted from Michigan or Sanger imputation servers), IMPUTE2 or PLINK files. To decrease the number of iterations needed for convergence when optimizing the parameter estimates in the Cox model we modified the R package survival; covariates in the model are first fit without the SNP, and those parameter estimates are used as initial points. We benchmarked gwasurvivr with other software capable of conducting genome wide survival analysis (genipe, SurvivalGWAS_SV, and GWASTools). gwasurvivr is significantly faster and shows better scalability as sample size, number of SNPs and number of covariates increases.
Availability and implementation: gwasurvivr, including source code, documentation, and vignette are available at: http://bioconductor.org/packages/gwasurvivr.
Supplementary information: Supplementary data are available at Bioinformatics online.},
	Author = {Rizvi, Abbas A and Karaesmen, Ezgi and Morgan, Martin and Preus, Leah and Wang, Junke and Sovic, Michael and Hahn, Theresa and Sucheston-Campbell, Lara E},
	Date-Added = {2018-12-13 11:35:03 -0500},
	Date-Modified = {2018-12-13 11:35:21 -0500},
	Doi = {10.1093/bioinformatics/bty920},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Month = {Nov},
	Pmid = {30395168},
	Pst = {aheadofprint},
	Title = {gwasurvivr: an R package for genome wide survival analysis},
	Year = {2018},
	Bdsk-Url-1 = {https://doi.org/10.1093/bioinformatics/bty920}}

@article{Lewis_2012,
	Abstract = {Genetic association studies are used to find candidate genes or genome regions that contribute to a specific disease by testing for a correlation between disease status and genetic variation. This article provides a broad outline of the design and analysis of such studies, focusing on case-control studies in candidate genes or regions.},
	Author = {Lewis, Cathryn M and Knight, Jo},
	Date-Added = {2018-11-11 19:46:12 -0500},
	Date-Modified = {2018-11-11 19:47:59 -0500},
	Doi = {10.1101/pdb.top068163},
	Journal = {Cold Spring Harb Protoc},
	Journal-Full = {Cold Spring Harbor protocols},
	Mesh = {Case-Control Studies; Genetic Association Studies; Genetic Predisposition to Disease; Humans},
	Month = {Mar},
	Number = {3},
	Pages = {297-306},
	Pmid = {22383645},
	Pst = {epublish},
	Title = {Introduction to genetic association studies},
	Volume = {2012},
	Year = {2012},
	Bdsk-Url-1 = {https://doi.org/10.1101/pdb.top068163}}

@mastersthesis{rizvi_master,
	Author = {Abbas A. Rizvi},
	Date-Added = {2018-09-13 23:43:10 -0400},
	Date-Modified = {2018-09-13 23:43:42 -0400},
	Month = {August},
	School = {University at Buffalo},
	Title = {Reprogramming androgen receptor and lysine-specific demethylase 1 transcriptome in castration-resistant prostate cancer},
	Year = {2015}}

@article{Clay_2017,
	Author = {Alyssa I. Clay-Gilmour and Theresa Hahn and Leah M. Preus and Kenan Onel and Andrew Skol and Eric Hungate and Qianqian Zhu and Christopher A. Haiman and Daniel O. Stram and Loreall Pooler and Xin Sheng and Li Yan and Qian Liu and Qiang Hu and Song Liu and Sebastiano Battaglia and Xiaochun Zhu and AnneMarie W. Block and Sheila N. J. Sait and Ezgi Karaesmen and Abbas A. Rizvi and Daniel J. Weisdorf and Christine B. Ambrosone and David Tritchler and Eva Ellinghaus and David Ellinghaus and Martin Stanulla and Jacqueline Clavel and Laurent Orsi and Stephen Spellman and Marcelo C. Pasquini and Philip L. McCarthy and Lara E. Sucheston-Campbell},
	Date-Added = {2018-09-13 23:32:08 -0400},
	Date-Modified = {2018-09-13 23:38:35 -0400},
	Journal = {Blood Advances},
	Lastchecked = {Thursday, September 13, 2018},
	Month = {September},
	Number = {20},
	Pages = {1717-1728},
	Title = {Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex},
	Url = {http://scholar.google.com/scholar_url?url=http%3A%2F%2Fwww.bloodadvances.org%2Fcontent%2F1%2F20%2F1717.abstract&hl=en&sa=T&oi=ggp&ct=res&cd=0&d=4375761072093748523&ei=sSubW-e7MY7EmgHJ3L3gCg&scisig=AAGBfm2IKyx5rd6M-HnXOAHC3_3qtEk3xQ&nossl=1&ws=896x264},
	Volume = {1},
	Year = {2017},
	Bdsk-Url-1 = {http://scholar.google.com/scholar_url?url=http%3A%2F%2Fwww.bloodadvances.org%2Fcontent%2F1%2F20%2F1717.abstract&hl=en&sa=T&oi=ggp&ct=res&cd=0&d=4375761072093748523&ei=sSubW-e7MY7EmgHJ3L3gCg&scisig=AAGBfm2IKyx5rd6M-HnXOAHC3_3qtEk3xQ&nossl=1&ws=896x264}}

@article{Sucheston_Campbell_2018,
	Author = {Sucheston-Campbell, Lara E. and Clay-Gilmour, Alyssa I. and Barlow, William E. and Budd, G. Thomas and Stram, Daniel O. and Haiman, Christopher A. and Sheng, Xin and Yan, Li and Zirpoli, Gary and Yao, Song and Jiang, Chen and Kouros, Owzar and Hershman, Dawn and Albain, Kathy S. and Hayes, Daniel F. and Moore, Halle C. and Hobday, Timothy J. and Stewart, James A. and Rizvi, Abbas A. and Isaacs, Claudine and Salim, Muhammad and Gralow, Jule R. and Hortobagyi, Gabriel N. and Livingston, Robert B. and Kroetz, Deanna L. and Ambrosone, Christine B.},
	Date-Added = {2018-09-13 23:29:22 -0400},
	Date-Modified = {2018-09-13 23:41:20 -0400},
	Doi = {10.1097/fpc.0000000000000318},
	Issn = {1744-6872},
	Journal = {Pharmacogenetics and Genomics},
	Month = {Feb},
	Number = {2},
	Pages = {49--55},
	Publisher = {Ovid Technologies (Wolters Kluwer Health)},
	Title = {Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci},
	Url = {http://dx.doi.org/10.1097/FPC.0000000000000318},
	Volume = {28},
	Year = {2018},
	Bdsk-Url-1 = {http://dx.doi.org/10.1097/FPC.0000000000000318},
	Bdsk-Url-2 = {http://dx.doi.org/10.1097/fpc.0000000000000318}}

@article{DeNies_2014,
	Author = {DeNies, Maxwell S. and Johnson, Jordan and Maliphol, Amanda B. and Bruno, Michael and Kim, Annabelle and Rizvi, Abbas and Rustici, Kevyn and Medler, Scott},
	Date-Added = {2018-09-13 23:12:29 -0400},
	Date-Modified = {2018-09-13 23:12:29 -0400},
	Doi = {10.1002/phy2.204},
	Issn = {2051-817X},
	Journal = {Physiological Reports},
	Month = {Jan},
	Number = {1},
	Pages = {e00204},
	Publisher = {Wiley},
	Title = {Diet-induced obesity alters skeletal muscle fiber types of male but not female mice},
	Url = {http://dx.doi.org/10.1002/phy2.204},
	Volume = {2},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/phy2.204}}

@article{Karaesmen_2017,
	Author = {Karaesmen, Ezgi and Rizvi, Abbas A. and Preus, Leah M. and McCarthy, Philip L. and Pasquini, Marcelo C. and Onel, Kenan and Zhu, Xiaochun and Spellman, Stephen and Haiman, Christopher A. and Stram, Daniel O. and et al.},
	Date-Added = {2018-09-13 23:12:08 -0400},
	Date-Modified = {2018-09-13 23:12:08 -0400},
	Doi = {10.1182/blood-2017-05-784637},
	Issn = {1528-0020},
	Journal = {Blood},
	Month = {Aug},
	Number = {13},
	Pages = {1585--1596},
	Publisher = {American Society of Hematology},
	Title = {Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant},
	Url = {http://dx.doi.org/10.1182/blood-2017-05-784637},
	Volume = {130},
	Year = {2017},
	Bdsk-Url-1 = {http://dx.doi.org/10.1182/blood-2017-05-784637}}

@article{Long_2018,
	Author = {Long, Mark D. and Singh, Prashant K. and Russell, James R. and Llimos, Gerard and Rosario, Spencer and Rizvi, Abbas and van den Berg, Patrick R. and Kirk, Jason and Sucheston-Campbell, Lara E. and Smiraglia, Dominic J. and et al.},
	Date-Added = {2018-09-13 23:11:33 -0400},
	Date-Modified = {2018-09-13 23:11:33 -0400},
	Doi = {10.1038/s41388-018-0450-6},
	Issn = {1476-5594},
	Journal = {Oncogene},
	Month = {Aug},
	Publisher = {Springer Nature America, Inc},
	Title = {The miR-96 and RARÎ³ signaling axis governs androgen signaling and prostate cancer progression},
	Url = {http://dx.doi.org/10.1038/s41388-018-0450-6},
	Year = {2018},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/s41388-018-0450-6}}
